Hikma Pharmaceuticals (HIK) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Hikma Pharmaceuticals

NOTE: This is based on 362 open tips for Hikma Pharmaceuticals (HIK)


Hikma Pharmaceuticals (HIK)
Latest Quote Price

1,774.00p

Hikma Pharmaceuticals (HIK)
Price Change (%)

-3.97%


Latest Bid : 1,767.00p Latest Ask : 1,769.00p
High Today : 1,810.00p Low Today : 1,751.00p
This Years High : 2,340.00p This Years Low : 1,751.00p
Volume : 664,357 MKT Cap : £3920.54M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Hikma Pharmaceuticals (HIK) Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

Hikma Pharmaceuticals (HIK) Latest Tips

Type Tipster SectorScore Start date Performance
Buy Berenberg Premium Only 2025-03-10 18:00:00 10/03/2025 -15.52%
Overweight JP Morgan Premium Only 2025-03-07 09:01:00 07/03/2025 -17.03%
Overweight JP Morgan Premium Only 2025-02-27 11:55:00 27/02/2025 -18.62%
Outperform RBC Capital Premium Only 2025-02-27 05:48:00 27/02/2025 -17.57%
Buy Berenberg Premium Only 2025-01-29 18:00:00 29/01/2025 -21.50%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Hikma Pharmaceuticals (HIK) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 1,767.00p Latest Ask : 1,769.00p
High Today : 1,810.00p Low Today : 1,751.00p
This Years High : 2,340.00p This Years Low : 1,751.00p
Volume : 664,357 MKT Cap : £3920.54M

Hikma Pharmaceuticals Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Hikma Pharmaceuticals Tips

Type Tipster SectorScore Start date Performance
Buy Berenberg Premium Only 2025-03-10 18:00:00 10/03/2025 -15.52%
Overweight JP Morgan Premium Only 2025-03-07 09:01:00 07/03/2025 -17.03%
Overweight JP Morgan Premium Only 2025-02-27 11:55:00 27/02/2025 -18.62%
Outperform RBC Capital Premium Only 2025-02-27 05:48:00 27/02/2025 -17.57%
Buy Berenberg Premium Only 2025-01-29 18:00:00 29/01/2025 -21.50%